Molina Healthcare, Inc (NYSE:MOH) Given Consensus Rating of “Hold” by Brokerages

Shares of Molina Healthcare, Inc (NYSE:MOH) have earned an average recommendation of “Hold” from the sixteen research firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $182.7333.

MOH has been the subject of a number of research analyst reports. Barclays upped their price target on Molina Healthcare from $161.00 to $199.00 and gave the stock an “underweight” rating in a report on Tuesday, May 26th. Truist Financial upped their price target on Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a report on Monday, May 11th. The Goldman Sachs Group cut their price target on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a report on Wednesday, February 11th. TD Cowen cut their price target on Molina Healthcare from $175.00 to $144.00 and set a “hold” rating for the company in a report on Monday, February 9th. Finally, Wall Street Zen upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd.

Molina Healthcare Stock Up 3.9%

MOH opened at $198.34 on Thursday. The business has a 50 day moving average price of $169.59 and a 200 day moving average price of $162.97. Molina Healthcare has a twelve month low of $121.06 and a twelve month high of $311.52. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. The firm has a market cap of $10.33 billion, a P/E ratio of 58.68 and a beta of 0.80.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same period in the previous year, the company earned $6.08 EPS. The company’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts forecast that Molina Healthcare will post 5.23 EPS for the current year.

Insider Buying and Selling

In other news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.44% of the company’s stock.

Institutional Trading of Molina Healthcare

Several large investors have recently made changes to their positions in the business. CenterBook Partners LP raised its holdings in shares of Molina Healthcare by 359.7% during the 3rd quarter. CenterBook Partners LP now owns 20,409 shares of the company’s stock worth $3,905,000 after buying an additional 15,969 shares in the last quarter. BNP Paribas Financial Markets grew its position in Molina Healthcare by 63.0% during the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock worth $76,248,000 after acquiring an additional 169,739 shares during the last quarter. Fiera Capital Corp grew its position in Molina Healthcare by 68.8% during the 3rd quarter. Fiera Capital Corp now owns 241,581 shares of the company’s stock worth $46,229,000 after acquiring an additional 98,431 shares during the last quarter. DDD Partners LLC bought a new stake in Molina Healthcare during the 3rd quarter worth $1,743,000. Finally, Timber Creek Capital Management LLC bought a new stake in Molina Healthcare during the 3rd quarter worth $4,467,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.